Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(62.5%)
Phase 1
1(12.5%)
Phase 2
1(12.5%)
Phase 4
1(12.5%)
8Total
N/A(5)
Phase 1(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT07163494Not Yet Recruiting

Occlusal Sensitivity to Articulating Foils in Patients With Temporomandibular Disorders and Healthy Controls

Role: collaborator

NCT07017127Not ApplicableRecruiting

Remission of Type 2 Diabetes With Lifestyle Intervention

Role: collaborator

NCT06314100Completed

The Effect of Aerosol Formed From Tobacco Heating Systems on the Microbiome of Supragingival Dental Biofilm

Role: collaborator

NCT06021743Unknown

The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis

Role: collaborator

NCT04573543Completed

The Role of Immune Semaphorins in NAFLD

Role: collaborator

NCT05726435Not ApplicableCompleted

Effects of Soluble Dietary Fiber on Sport Efficiency and Fatigue Delay in Top Basketball Players

Role: collaborator

NCT03334461Phase 2Completed

Immunological and Regenerative Implications of Corrosion of Dental Materials

Role: collaborator

NCT05307718Unknown

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

Role: collaborator

NCT05008094Unknown

The Epidemiology of Parkinson's Disease in Croatia and the Influence of Genetic Factors and Microbiota on the Progression and Treatment Outcomes of the Disease (GiOPARK)

Role: collaborator

NCT04694274Unknown

Genetic Polymorphisms and Their Association With Temporomandibular Disorders

Role: lead

NCT04369534Phase 4Completed

Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction

Role: collaborator

NCT03534791Not ApplicableCompleted

Brief Reminders as Intervention for Greater Engagement of Cochrane Translators

Role: collaborator

NCT02918656Not ApplicableCompleted

Presenting Summary Information From Cochrane Systematic Reviews

Role: collaborator

NCT03529604Unknown

Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients

Role: collaborator

NCT03029494Not ApplicableUnknown

Oxidative Stress and Opiorphin in Temporomandibular Disorders

Role: lead

NCT02403908Phase 1Unknown

Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAH

Role: collaborator

All 16 trials loaded